This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are Options Traders Betting on a Big Move in Primerica (PRI) Stock?
by Zacks Equity Research
Investors need to pay close attention to Primerica (PRI) stock based on the movements in the options market lately.
Primerica (PRI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Primerica (PRI) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Primerica (PRI) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Primerica (PRI) delivered earnings and revenue surprises of 5.84% and 0.78%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Primerica (PRI) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Primerica (PRI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Primerica (PRI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Primerica (PRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Stocks to Watch From the Prospering Life Insurance Industry
by Tanuka De
Redesigning and repricing of products and services and a rising rate environment are likely to help Zacks Life Insurance industry players like RGA, PRI, VOYA, LNC and BHF. These companies are investing heavily in digitization.
Primerica (PRI) Stock Rises 15% YTD: Will the Rally Last?
by Zacks Equity Research
Primerica (PRI) is set to grow on a compelling portfolio, strong market presence and a solid capital position.
Here's Why You Should Stay Invested in Primerica (PRI) Stock
by Zacks Equity Research
A compelling portfolio, strong market presence and a solid capital position poise Primerica (PRI) for growth.
Primerica (PRI) Stock Declines Since Q1 Earnings Miss Estimates
by Zacks Equity Research
Primerica (PRI) expects growth in the number of policies issued between 3 and 5% in 2024.
Primerica (PRI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Primerica (PRI) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Primerica (PRI) Q1 Earnings Lag Estimates
by Zacks Equity Research
Primerica (PRI) delivered earnings and revenue surprises of -4.87% and 0.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Countdown to Primerica (PRI) Q1 Earnings: Wall Street Forecasts for Key Metrics
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Primerica (PRI), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
Reinsurance Group (RGA) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Reinsurance Group (RGA) delivered earnings and revenue surprises of 33.48% and 36.19%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Manulife Financial, Sun Life Financial, Reinsurance Group, Primerica and Lincoln National
by Zacks Equity Research
Manulife Financial, Sun Life Financial, Reinsurance Group, Primerica and Lincoln National have been highlighted in this Industry Outlook article.
5 Life Insurance Stocks to Watch Amid Industry Challenges
by Tanuka De
Redesigning and repricing of products and services and a rising rate environment are likely to help Zacks Life Insurance industry players like MFC, SLF, RGA, PRI and LNC. These companies are investing heavily in digitization.
Is a Beat in Store for Cboe Global (CBOE) in Q1 Earnings?
by Zacks Equity Research
Cboe Global's (CBOE) Q1 results are likely to reflect improved index options trading volumes, higher physical port fees and proprietary market data fees, as well as strong proprietary products.
BRP Group (BRP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
BRP Group (BRP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Insurers Set to Outperform Estimates This Earnings Season
by Tanuka De
Better pricing, exposure growth, accelerated digitalization and sturdy capital are expected to help AFL, AXS, HMN and PRI outperform first-quarter earnings estimates.
Should You Buy Berkshire Hathaway (BRK.B) Ahead of Q1 Earnings?
by Zacks Equity Research
Berkshire Hathaway's (BRK.B) first-quarter results are likely to reflect improved pricing, favorable reserve development, a larger investment asset base and a higher reinvestment rate.
How Should You Play MetLife (MET) Ahead of Q1 Earnings?
by Zacks Equity Research
MetLife's (MET) Q1 results are likely to reflect gains from strong contributions from Group Benefits, RIS and Asia segments, partly offset by an elevated expense level.
Here's How You Should Play Aflac (AFL) Ahead of Q1 Earnings
by Zacks Equity Research
Aflac's (AFL) Q1 results are likely to indicate favorable persistency rates and new business growth, partly offset by a higher expense ratio within the U.S. segment.
Primerica (PRI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Primerica (PRI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Stay Invested in Primerica (PRI) Stock
by Zacks Equity Research
Primerica's (PRI) compelling portfolio, strong market presence, sturdy distribution channel and solid capital position poise it well for growth.
5 Mid-Cap Stocks to Buy in a Volatile April
by Nalak Das
We have narrowed our search to five mid-caps that have strong potential for 2024. These are ALSN, SM, JXN, PRI and LANC.
Manulife (MFC) Shares Up 11% YTD: More Room for Upside?
by Zacks Equity Research
Manulife (MFC) appears well-poised for growth on its strengthening Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position.